| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-10 22:07:21 UTC |
|---|
| Update Date | 2021-09-26 22:53:10 UTC |
|---|
| HMDB ID | HMDB0245008 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 2-Aminobenzimidazole |
|---|
| Description | 2-aminobenzimidazole, also known as benzimidazol-2-ylamine, belongs to the class of organic compounds known as benzimidazoles. These are organic compounds containing a benzene ring fused to an imidazole ring (five member ring containing a nitrogen atom, 4 carbon atoms, and two double bonds). 2-aminobenzimidazole is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a significant number of articles have been published on 2-aminobenzimidazole. This compound has been identified in human blood as reported by (PMID: 31557052 ). 2-aminobenzimidazole is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 2-Aminobenzimidazole is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | InChI=1S/C7H7N3/c8-7-9-5-3-1-2-4-6(5)10-7/h1-4H,(H3,8,9,10) |
|---|
| Synonyms | | Value | Source |
|---|
| 2-Iminobenzimidazoline | ChEBI | | Benzimidazol-2-ylamine | ChEBI | | 2-Aminobenzimidazole hydrochloride | MeSH | | 2-Aminobenzimidazole monohydrochloride | MeSH | | 2-Aminobenzimidazole sulfate | MeSH | | 2-Aminobenzimidazole sulfate (2:1) | MeSH | | 2-Aminobenzimidazole, conjugate monoacid | MeSH | | 2-Aminobenzimidazole monobenzoate | MeSH | | 2-Aminobenzimidazole monoperchlorate | MeSH | | 2-Aminobenzimidazole monosulfate | MeSH | | 2-Aminobenzimidazole tartrate(2:1), (L)-(+)-isomer | MeSH |
|
|---|
| Chemical Formula | C7H7N3 |
|---|
| Average Molecular Weight | 133.1506 |
|---|
| Monoisotopic Molecular Weight | 133.063997239 |
|---|
| IUPAC Name | 2,3-dihydro-1H-1,3-benzodiazol-2-imine |
|---|
| Traditional Name | caswell no. 033AA |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | N=C1NC2=CC=CC=C2N1 |
|---|
| InChI Identifier | InChI=1S/C7H7N3/c8-7-9-5-3-1-2-4-6(5)10-7/h1-4H,(H3,8,9,10) |
|---|
| InChI Key | JWYUFVNJZUSCSM-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzimidazoles. These are organic compounds containing a benzene ring fused to an imidazole ring (five member ring containing a nitrogen atom, 4 carbon atoms, and two double bonds). |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzimidazoles |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Benzimidazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzimidazole
- Benzenoid
- Aminoimidazole
- Heteroaromatic compound
- Imidazole
- Azole
- Azacycle
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Primary amine
- Organonitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 9.2149 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.15 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1274.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 357.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 65.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 231.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 247.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 267.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 287.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 640.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 614.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 286.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 691.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 209.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 251.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 598.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 278.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 220.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 2-Aminobenzimidazole,1TMS,isomer #1 | C[Si](C)(C)N=C1[NH]C2=CC=CC=C2[NH]1 | 1555.9 | Semi standard non polar | 33892256 | | 2-Aminobenzimidazole,1TMS,isomer #1 | C[Si](C)(C)N=C1[NH]C2=CC=CC=C2[NH]1 | 1553.6 | Standard non polar | 33892256 | | 2-Aminobenzimidazole,1TMS,isomer #1 | C[Si](C)(C)N=C1[NH]C2=CC=CC=C2[NH]1 | 2412.4 | Standard polar | 33892256 | | 2-Aminobenzimidazole,1TMS,isomer #2 | C[Si](C)(C)N1C(=N)[NH]C2=CC=CC=C21 | 1699.5 | Semi standard non polar | 33892256 | | 2-Aminobenzimidazole,1TMS,isomer #2 | C[Si](C)(C)N1C(=N)[NH]C2=CC=CC=C21 | 1611.5 | Standard non polar | 33892256 | | 2-Aminobenzimidazole,1TMS,isomer #2 | C[Si](C)(C)N1C(=N)[NH]C2=CC=CC=C21 | 2380.9 | Standard polar | 33892256 | | 2-Aminobenzimidazole,2TMS,isomer #1 | C[Si](C)(C)N=C1[NH]C2=CC=CC=C2N1[Si](C)(C)C | 1754.8 | Semi standard non polar | 33892256 | | 2-Aminobenzimidazole,2TMS,isomer #1 | C[Si](C)(C)N=C1[NH]C2=CC=CC=C2N1[Si](C)(C)C | 1664.9 | Standard non polar | 33892256 | | 2-Aminobenzimidazole,2TMS,isomer #1 | C[Si](C)(C)N=C1[NH]C2=CC=CC=C2N1[Si](C)(C)C | 2116.5 | Standard polar | 33892256 | | 2-Aminobenzimidazole,2TMS,isomer #2 | C[Si](C)(C)N1C(=N)N([Si](C)(C)C)C2=CC=CC=C21 | 1863.6 | Semi standard non polar | 33892256 | | 2-Aminobenzimidazole,2TMS,isomer #2 | C[Si](C)(C)N1C(=N)N([Si](C)(C)C)C2=CC=CC=C21 | 1770.2 | Standard non polar | 33892256 | | 2-Aminobenzimidazole,2TMS,isomer #2 | C[Si](C)(C)N1C(=N)N([Si](C)(C)C)C2=CC=CC=C21 | 2071.0 | Standard polar | 33892256 | | 2-Aminobenzimidazole,3TMS,isomer #1 | C[Si](C)(C)N=C1N([Si](C)(C)C)C2=CC=CC=C2N1[Si](C)(C)C | 1945.9 | Semi standard non polar | 33892256 | | 2-Aminobenzimidazole,3TMS,isomer #1 | C[Si](C)(C)N=C1N([Si](C)(C)C)C2=CC=CC=C2N1[Si](C)(C)C | 1774.7 | Standard non polar | 33892256 | | 2-Aminobenzimidazole,3TMS,isomer #1 | C[Si](C)(C)N=C1N([Si](C)(C)C)C2=CC=CC=C2N1[Si](C)(C)C | 1893.4 | Standard polar | 33892256 | | 2-Aminobenzimidazole,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1[NH]C2=CC=CC=C2[NH]1 | 1831.8 | Semi standard non polar | 33892256 | | 2-Aminobenzimidazole,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1[NH]C2=CC=CC=C2[NH]1 | 1726.2 | Standard non polar | 33892256 | | 2-Aminobenzimidazole,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1[NH]C2=CC=CC=C2[NH]1 | 2522.2 | Standard polar | 33892256 | | 2-Aminobenzimidazole,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=N)[NH]C2=CC=CC=C21 | 1922.2 | Semi standard non polar | 33892256 | | 2-Aminobenzimidazole,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=N)[NH]C2=CC=CC=C21 | 1814.2 | Standard non polar | 33892256 | | 2-Aminobenzimidazole,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=N)[NH]C2=CC=CC=C21 | 2438.3 | Standard polar | 33892256 | | 2-Aminobenzimidazole,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1[NH]C2=CC=CC=C2N1[Si](C)(C)C(C)(C)C | 2136.5 | Semi standard non polar | 33892256 | | 2-Aminobenzimidazole,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1[NH]C2=CC=CC=C2N1[Si](C)(C)C(C)(C)C | 2049.9 | Standard non polar | 33892256 | | 2-Aminobenzimidazole,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1[NH]C2=CC=CC=C2N1[Si](C)(C)C(C)(C)C | 2301.8 | Standard polar | 33892256 | | 2-Aminobenzimidazole,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=N)N([Si](C)(C)C(C)(C)C)C2=CC=CC=C21 | 2133.8 | Semi standard non polar | 33892256 | | 2-Aminobenzimidazole,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=N)N([Si](C)(C)C(C)(C)C)C2=CC=CC=C21 | 2155.3 | Standard non polar | 33892256 | | 2-Aminobenzimidazole,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=N)N([Si](C)(C)C(C)(C)C)C2=CC=CC=C21 | 2236.0 | Standard polar | 33892256 | | 2-Aminobenzimidazole,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1N([Si](C)(C)C(C)(C)C)C2=CC=CC=C2N1[Si](C)(C)C(C)(C)C | 2358.2 | Semi standard non polar | 33892256 | | 2-Aminobenzimidazole,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1N([Si](C)(C)C(C)(C)C)C2=CC=CC=C2N1[Si](C)(C)C(C)(C)C | 2334.5 | Standard non polar | 33892256 | | 2-Aminobenzimidazole,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1N([Si](C)(C)C(C)(C)C)C2=CC=CC=C2N1[Si](C)(C)C(C)(C)C | 2268.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 2-Aminobenzimidazole GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-2900000000-abc127738a6c29ff06cf | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 2-Aminobenzimidazole GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 10V, Positive-QTOF | splash10-001i-0900000000-6c16cdc65ba91490242c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 45V, Positive-QTOF | splash10-001i-0900000000-559139a9cbb3f402b7ce | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 20V, Positive-QTOF | splash10-001i-0900000000-45945f33159f6785a0b3 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 75V, Positive-QTOF | splash10-001i-4900000000-4340ae07e25cda4fa5fc | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 60V, Positive-QTOF | splash10-001i-1900000000-db1f976252016bbec0fd | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 50V, Positive-QTOF | splash10-001i-0900000000-f8a29f3c077d7558c831 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 15V, Positive-QTOF | splash10-001i-0900000000-90a5c28887117b4cdf27 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 40V, Positive-QTOF | splash10-001i-0900000000-21ccac515ebe8555b558 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 30V, Positive-QTOF | splash10-001i-0900000000-f0b8e85e4a8f3df0df28 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 90V, Positive-QTOF | splash10-001i-2900000000-e3bd59d94c640895cc48 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 75V, Positive-QTOF | splash10-001i-0900000000-a3fdcb26eae87abb5843 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 65V, Positive-QTOF | splash10-0006-9000000000-6b70e49f6699b299a92d | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 90V, Positive-QTOF | splash10-001i-3900000000-7475d8cee4c70fe8bb6c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 60V, Positive-QTOF | splash10-001i-0900000000-ab66096ddfca6bafce99 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 45V, Positive-QTOF | splash10-001i-0900000000-a3d13d4923072148370d | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 25V, Positive-QTOF | splash10-001i-0900000000-a4cb00315025adf15988 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 75V, Positive-QTOF | splash10-001i-0900000000-204f733c9f4e9d31023e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 35V, Positive-QTOF | splash10-0006-9000000000-c5216e20a59eaca8e6f0 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzimidazole 180V, Positive-QTOF | splash10-014l-9100000000-f09ec09d7db254a375c8 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Aminobenzimidazole 10V, Positive-QTOF | splash10-001i-0900000000-92adec0b16441ca35c47 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Aminobenzimidazole 20V, Positive-QTOF | splash10-001i-0900000000-6c295d59fec82d35d8cf | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Aminobenzimidazole 40V, Positive-QTOF | splash10-014i-2900000000-076fba607533f5a3e3d6 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Aminobenzimidazole 10V, Negative-QTOF | splash10-001i-0900000000-20670003dfad093226d2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Aminobenzimidazole 20V, Negative-QTOF | splash10-001i-0900000000-170b4bf247573f77ea2b | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Aminobenzimidazole 40V, Negative-QTOF | splash10-0006-9500000000-3a87216a1ffa3800d481 | 2016-08-03 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|